• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

个体化研究结果的披露:一种预防措施。

Disclosure of individualized research results: a precautionary approach.

机构信息

National Institute for Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA.

出版信息

Account Res. 2011 Nov;18(6):382-97. doi: 10.1080/08989621.2011.622172.

DOI:10.1080/08989621.2011.622172
PMID:22011068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3953618/
Abstract

Assessing and managing risks to participants is a central point of contention in the debate about disclosing individualized research results. Those who favor disclosure of only clinically significant results think that disclosing clinically insignificant results is risky and costly, and that harm prevention should take precedence over other ethical considerations. Those who favor giving participants the option of full disclosure regard these risks as insubstantial, and think that obligations to benefit participants and promote their autonomy and right to know outweigh the obligation to prevent harm or financial considerations. The risks of disclosing clinically insignificant research results are currently not quantifiable, due to lack of empirical data. The precautionary principle provides some insight into this debate because it applies to decision-making concerning risks that are plausible but not quantifiable. A precautionary approach would favor full disclosure of individualized results with appropriate safeguards to prevent, minimize, or mitigate risks to participants, such as: validating testing methods; informing participants about their options for receiving tests results and the potential benefits and risks related to receiving results; assessing participants' comfort with handling uncertainty; providing counseling and advice to participants; following-up with individuals who receive tests results; and forming community advisory boards to help investigators deal with issues related to disclosure.

摘要

评估和管理参与者的风险是关于披露个体化研究结果的争论中的一个核心问题。那些赞成只披露有临床意义结果的人认为披露无临床意义的结果是有风险和代价的,预防伤害应该优先于其他伦理考虑。那些赞成让参与者有选择充分披露的人则认为这些风险微不足道,认为有义务使参与者受益,并促进他们的自主权和知情权,这比预防伤害或财务考虑更为重要。由于缺乏经验数据,目前还无法量化披露无临床意义的研究结果的风险。预防原则为这场争论提供了一些启示,因为它适用于涉及有合理但无法量化的风险的决策。谨慎方法将倾向于充分披露个体化结果,并采取适当的保障措施来预防、最小化或减轻对参与者的风险,例如:验证测试方法;告知参与者有关接受测试结果的选择,以及与接受结果相关的潜在益处和风险;评估参与者处理不确定性的舒适度;为参与者提供咨询和建议;对接受测试结果的个人进行随访;并组建社区咨询委员会,帮助研究人员处理与披露相关的问题。

相似文献

1
Disclosure of individualized research results: a precautionary approach.个体化研究结果的披露:一种预防措施。
Account Res. 2011 Nov;18(6):382-97. doi: 10.1080/08989621.2011.622172.
2
Informed recruitment in partner studies of HIV transmission: an ethical issue in couples research.艾滋病病毒传播伴侣研究中的知情招募:伴侣研究中的一个伦理问题。
BMC Med Ethics. 2009 Aug 27;10:14. doi: 10.1186/1472-6939-10-14.
3
Disclosure of individual surgeon's performance rates during informed consent: ethical and epistemological considerations.在知情同意过程中披露个体外科医生的手术成功率:伦理和认识论考量
Ann Surg. 2007 Apr;245(4):507-13. doi: 10.1097/01.sla.0000242713.82125.d1.
4
Questioning the quantitative imperative: decision aids, prevention, and the ethics of disclosure.质疑量化指令:决策辅助、预防和披露伦理。
Hastings Cent Rep. 2011 Mar-Apr;41(2):30-9. doi: 10.1353/hcr.2011.0029.
5
When Should Genome Researchers Disclose Misattributed Parentage?基因组研究人员应在何时披露错误认定的亲子关系?
Hastings Cent Rep. 2015 Jul-Aug;45(4):28-36. doi: 10.1002/hast.452. Epub 2015 Feb 11.
6
Principles of Clinical Ethics and Their Application to Practice.临床伦理学原则及其在实践中的应用。
Med Princ Pract. 2021;30(1):17-28. doi: 10.1159/000509119. Epub 2020 Jun 4.
7
To tell the truth, the whole truth, may do patients harm: the problem of the nocebo effect for informed consent.说实话,全盘托出,可能对患者有害:知情同意中的反安慰剂效应问题。
Am J Bioeth. 2012;12(3):22-9. doi: 10.1080/15265161.2011.652798.
8
Transparency and self-censorship in shared decision-making.共同决策中的透明度与自我审查。
Am J Bioeth. 2007 Jul;7(7):44-6. doi: 10.1080/15265160701399800.
9
Aligning ethics with medical decision-making: the quest for informed patient choice.使伦理与医疗决策保持一致:寻求患者的知情选择。
J Law Med Ethics. 2010 Spring;38(1):85-97. doi: 10.1111/j.1748-720X.2010.00469.x.
10
Ethical dilemmas encountered by clinical researchers.临床研究人员遇到的伦理困境。
J Clin Ethics. 2005 Fall;16(3):267-76.

引用本文的文献

1
Revised Common Rule Changes to the Consent Process and Consent Form.对同意程序和同意书的修订后的《通用规则》变更
Ochsner J. 2020 Spring;20(1):62-75. doi: 10.31486/toj.19.0055.
2
Potentials and Challenges of the Health Data Cooperative Model.健康数据合作模式的潜力与挑战。
Public Health Genomics. 2017;20(6):321-331. doi: 10.1159/000489994. Epub 2018 Jun 22.
3
Amnestic MCI patients' experiences after disclosure of their amyloid PET result in a research context.遗忘型轻度认知障碍患者在研究背景下得知其淀粉样蛋白 PET 结果后的体验。
Alzheimers Res Ther. 2017 Dec 2;9(1):92. doi: 10.1186/s13195-017-0321-3.
4
Clinical verification of genetic results returned to research participants: findings from a Colon Cancer Family Registry.返回给研究参与者的基因检测结果的临床验证:来自结肠癌家族登记处的发现
Mol Genet Genomic Med. 2017 Nov;5(6):700-708. doi: 10.1002/mgg3.328. Epub 2017 Aug 23.

本文引用的文献

1
Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group.向研究参与者报告基因研究结果的伦理与实践指南:美国国立心肺血液研究所工作组的更新指南
Circ Cardiovasc Genet. 2010 Dec;3(6):574-80. doi: 10.1161/CIRCGENETICS.110.958827.
2
Understanding preferences for disclosure of individual biomarker results among participants in a longitudinal birth cohort.了解纵向出生队列参与者对个体生物标志物结果披露的偏好。
J Med Ethics. 2010 Dec;36(12):736-40. doi: 10.1136/jme.2010.036517. Epub 2010 Oct 8.
3
Sharing unexpected biomarker results with study participants.与研究参与者分享意外的生物标志物结果。
Environ Health Perspect. 2011 Jan;119(1):1-5. doi: 10.1289/ehp.1001988. Epub 2010 Sep 29.
4
To know or not to know: ethical issues related to early diagnosis of Alzheimer's disease.知晓与否:与阿尔茨海默病早期诊断相关的伦理问题。
Int J Alzheimers Dis. 2010 Jun 27;2010:841941. doi: 10.4061/2010/841941.
5
Institutional review board challenges related to community-based participatory research on human exposure to environmental toxins: a case study.与基于社区的参与式研究人类暴露于环境毒素相关的机构审查委员会挑战:案例研究。
Environ Health. 2010 Jul 16;9:39. doi: 10.1186/1476-069X-9-39.
6
Offering individual genetic research results: context matters.提供个体基因研究结果:背景很重要。
Sci Transl Med. 2010 Jun 30;2(38):38cm20. doi: 10.1126/scitranslmed.3000952.
7
Prospective biorepository participants' perspectives on access to research results.前瞻性生物样本库参与者对获取研究结果的看法。
J Empir Res Hum Res Ethics. 2009 Sep;4(3):99-111. doi: 10.1525/jer.2009.4.3.99.
8
The precautionary principle in the context of mobile phone and base station radiofrequency exposures.手机与基站射频辐射环境下的预防原则
Environ Health Perspect. 2009 Sep;117(9):1329-32. doi: 10.1289/ehp.0900727. Epub 2009 May 18.
9
Environmental health research and the observer's dilemma.环境卫生研究与观察者困境
Environ Health Perspect. 2009 Aug;117(8):1191-4. doi: 10.1289/ehp.0900861. Epub 2009 May 26.
10
A precautionary principle for dual use research in the life sciences.生命科学两用研究的防范原则。
Bioethics. 2011 Jan;25(1):1-8. doi: 10.1111/j.1467-8519.2009.01740.x.